Altogether these data indicate that the expression of the drug metabolizing enzymes CYP2C8, UGT2B4 and UGT2B17, and transporter ABCB4 was positively regulated by SPIN1 in breast cancer. Here, UGT2B4 is linked to breast carcinoma.